Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
John Bridgewater, Peter Fletcher, Daniel H. Palmer, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 18, pp. 2048-2057
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
Demetrios Moris, Manisha Palta, Charles Kim, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 2, pp. 198-222
Open Access | Times Cited: 260
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Kohei Nakachi, Masafumi Ikeda, Masaru Konishi, et al.
The Lancet (2023) Vol. 401, Iss. 10372, pp. 195-203
Closed Access | Times Cited: 130
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 126
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial
Robert S. Fichtinger, Luca Aldrighetti, Mohammad Abu Hilal, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 15, pp. 1799-1809
Open Access | Times Cited: 23
Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers
Xin Wang, Anna Saborowski, Gonzalo Sapisochín, et al.
Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 2
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma
Jeremy Sharib, Kristen E. Rhodin, Annie Liu, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2456-2466
Closed Access | Times Cited: 1
Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study
Anita Balakrishnan, Petros Barmpounakis, Nikolaos Demiris, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101951-101951
Open Access | Times Cited: 27
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial
Hyehyun Jeong, Kyu‐pyo Kim, Jae Ho Jeong, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1540-1549
Closed Access | Times Cited: 26
Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
Justin H. Lo, Rajiv Agarwal, Laura W. Goff, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3312-3312
Open Access | Times Cited: 24
Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies
Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)
Gaël S. Roth, Loïc Verlingue, Matthieu Sarabi, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114000-114000
Open Access | Times Cited: 8
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection
James Yu, Aiwu Ruth He, Mahmoud Ouf, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access | Times Cited: 1
Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma
Laura Alaimo, Henrique A. Lima, Zorays Moazzam, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 9, pp. 5406-5415
Closed Access | Times Cited: 21
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma
Margaret Wheless, Rajiv Agarwal, Laura W. Goff, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 1, pp. 127-160
Open Access | Times Cited: 7
Management of Intrahepatic Cholangiocarcinoma: A Narrative Review
Carolyn Tsung, Patrick L. Quinn, Aslam Ejaz
Cancers (2024) Vol. 16, Iss. 4, pp. 739-739
Open Access | Times Cited: 5
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma
Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 9, pp. 1018-1042
Open Access | Times Cited: 5
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
Monica Niger, Federico Nichetti, Lorenzo Fornaro, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report
James B. Yu, Trenton A Avriett, Christopher M Ray, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 485-490
Open Access | Times Cited: 4
Biliary tract cancer
Kjetil Søreide, Cristina Dopazo, Frederik Berrevoet, et al.
European Journal of Surgical Oncology (2024), pp. 108489-108489
Open Access | Times Cited: 4
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
Changhoon Yoo, Hyehyun Jeong, Jae Ho Jeong, et al.
Journal of Hepatology (2024)
Open Access | Times Cited: 4
Prediction of survival after pancreatoduodenectomy for distal cholangiocarcinoma: independent external validation of a prognostic model for 3-year overall survival in Sweden
Johannes Byrling, Bodil Andersson
Scandinavian Journal of Gastroenterology (2025), pp. 1-7
Open Access
Prognostic Significance of Lymph Node Ratio in Intrahepatic and Extrahepatic Cholangiocarcinomas
Andrii Khomiak, Sumaya Abdul Ghaffar, Salvador Rodriguez Franco, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 220-220
Open Access
Prognostic Factors for Patients with T2/T3 Gallbladder Cancer: Does Extent of Resection Matter?
Stacy M. Goins, Kristen E. Rhodin, Austin M. Eckhoff, et al.
Surgical Oncology Insight (2025), pp. 100126-100126
Open Access
Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma
C. O'Donnell, Umair Majeed, Michael Rutenberg, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 82-82
Open Access
Cirugía del colangiocarcinoma intrahepático y perihiliar
A. Facque, Nicolas Golse
EMC - Técnicas Quirúrgicas - Aparato Digestivo (2025) Vol. 41, Iss. 1, pp. 1-20
Closed Access
Page 1 - Next Page

Scroll to top